Symbols / SLN Stock $8.13 +2.01% Silence Therapeutics plc

Healthcare • Biotechnology • United Kingdom • NGM
SLN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 384.01M Enterprise Value 1.04B Income -88.61M Sales 559.00K Book/sh 1.32 Cash/sh 0.60
Dividend Yield — Payout 0.00% Employees 88 IPO — P/E — Forward P/E -11.29
PEG — P/S 686.96 P/B 6.16 P/C — EV/EBITDA -12.78 EV/Sales 1868.35
Quick Ratio 8.06 Current Ratio 8.72 Debt/Eq 0.26 LT Debt/Eq — EPS (ttm) -1.89 EPS next Y -0.72
EPS Growth — Revenue Growth -99.90% Earnings 2026-05-07 ROA -30.79% ROE -90.27% ROIC —
Gross Margin 61.54% Oper. Margin -371.50% Profit Margin 0.00% Shs Outstand 47.23M Shs Float 74.75M Short Float 4.91%
Short Ratio 4.99 Short Interest — 52W High 8.14 52W Low 3.08 Beta 1.33 Avg Volume 308.92K
Volume 8.62K Target Price $32.80 Recom None Prev Close $7.97 Price $8.13 Change 2.01%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-15.07
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest SLN news

No recent news from Yahoo. Try the RSS feed for latest SLN news.

Insider Transactions

No recent insider transactions.

Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category